Gadd45 proteins as critical signal transducers linking NF-κB to MAPK cascades

Current Cancer Drug Targets

Volumn 9, Issue 8, 2009, Pages 915-930

  Yang, Z ^a   Song, L ^a,b   Huang, C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cell survival and apoptosis; Gadd45 ; Gadd45 ; Gadd45 ; JNK; NF B; P38

Indexed keywords

1 [5 HYDROXY 2 (2 THIENYL) 4 QUINAZOLINYLAMINO] 3 METHYL 2,5 PYRROLEDIONE; 5 AZA 2' DEOXYCYTIDINE; 5,6 DIHYDROAZACITIDINE; ARSENIC TRIOXIDE; AZACITIDINE; BUTYRIC ACID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45GAMMA; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MG 98; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROMOTER; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL ACTIVITY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL STIMULATION; CELL SURVIVAL; CLINICAL TRIAL; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; NONHUMAN; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL SURVIVAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 74949116151     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909790192383     Document Type: Review

References (231)

1. Vairapandi, M.; Balliet, A. G.; Hoffman, B.; Liebermann, D. A. Gadd45B and Gadd45γ Are Cdc2/Cyclinb1 Kinase Inhibitors with a Role in S and G2/M Cell Cycle Checkpoints Induced by Genotoxic Stress. J. Cell. Physiol. 2002, 192, 327-338.
2. Shih, R. S.; Wong, S. H.; Schoene, N. W.; Lei, K. Y. Suppression of Gadd45 Alleviates the G2/M Blockage and the Enhanced Phosphorylation of P53 and P38 in Zinc Supplemented Normal Human Bronchial Epithelial Cells. Exp. Biol. Med. 2008, 233, 317-327.
3. Zhang, W.; Bae, I.; Krishnaraju, K.; Azam, N.; Fan, W.; Smith, K.; Hoffman, B.; Liebermann, D. A. Cr6: A Third Member in the Myd118 and Gadd 45 Gene Family Which Functions in Negative Growth Control. Oncogene 1999, 18, 4899-4907.
4. Smith, M. L.; Ford, J. M.; Hollander, M. C.; Bortnick, R. A.; Amundson, S. A.; Seo, Y. R.; Deng, C.; Hanawalt, P. C.; Fornace, A. J., Jr. P53-Mediated DNA Repair Responses to Uv Radiation: Studies of Mouse Cells Lacking P53, P21, and/or Gadd45 Genes. Mol. Cell. Biol. 2000, 20, 3705-3714.
5. Vairapandi, M.; Balliet, A.; Fornace, A. J.; Hoffman, B.; Liebermann, D. A. The Differentiation Primary Response Gene Myd118, Related to Gadd45, Encodes for a Nuclear Protein Which Interacts with Pcna and P21waf1/Cip1. Oncogene 1996, 12, 2579-2594.
6. Takekawa, M.; Saito, H. A Family of Stress-Inducible Gadd45-Like Proteins Mediate Activation of the Stress-Responsive Mtk1/Mekk4 Mapkkk. Cell. 1998, 95, 521-530.
7. Sheikh, M. S.; Hollander, M. C.; Fornace, A. J. Role of Gadd45 in Apoptosis. Biochem. Pharm. 2000, 59, 43-45.
8. Xu, J. H.; Qiu, W.; Wang, Y. W.; Xu, J.; Tong, J. X.; Gao, L. J.; Xu, W. H.; Wu, Y. Q. Gene Expression Profile and Overexpression of Apoptosis-Related Genes (Ngfi-B and Gadd 45 Gamma) in Early Phase of Thy-1 Nephritis Model. Cell Tissue Res. 2006, 326, 159-168.
9. Gupta, M.; Gupta, S. K.; Hoffman, B.; Liebermann, D. A. Gadd45β and Gadd45β Protect Hematopoietic Cells from Uv-Induced Apoptosis Via Distinct Signaling Pathways, Including P38 Activation and Jnk Inhibition. J. Biol. Chem. 2006, 281, 17552-17558.
10. Tront, J. S.; Hoffman, B.; Liebermann, D. A. Gadd45α Suppresses Ras-Driven Mammary Tumorigenesis by Activation of C-Jun Nh2-Terminal Kinase and P38 Stress Signaling Resulting in Apoptosis and Senescence. Cancer Res. 2006, 66, 8448-8454.
11. Hollander, M.; Sheikh, M.; Bulavin, D.; Lundgren, K.; Augeri-Henmueller, L.; Shehee, R.; Molinaro, T. A.; Kim, K. E.; Tolosa, E.; Ashwell, J. D.; Rosenberg, M. P.; Zhan, Q.; Fernández-Salguero, P. M.; Morgan, M. F.; Deng, C.; Fornace, A. J., Jr. Genomic Instability in Gadd45a-Deficient Mice. Nat. Genet. 1999, 23, 176-184.
12. Vinson, R. K.; Hales, B. F. Genotoxic Stress Response Gene Expression in the Mid-Organogenesis Rat Conceptus. Toxicol. Sci. 2003, 74, 157-164.
13. Jianfei, Y.; Hong, Z.; Theresa, M.; Wenjun, O.; Kenneth, M. M. IL-18-Stimulated Gadd45 Required in Cytokine-Induced, but Not TCR-Induced, IFN- Production. Nat. Immunol. 2001, 2, 157-164.
14. Lu, B. The Molecular Mechanisms That Control Function and Death of Effector Cd4+ T Cells. Immunol. Res. 2006, 36, 275-282.
15. Lu, B.; Ferrandino, A. F.; Flavell, R. Gadd45beta Is Important for Perpetuating Cognate and Inflammatory Signals in T Cells. Nat. Immunol. 2004, 5, 38-44.
16. Fornace, A.; Nebert, D.; Hollander, M.; Luethy, J.; Papathanasiou, M.; Fargnoli, J.; Holbrook, N. J. Mammalian Genes Coordinately Regulated by Growth Arrest Signals and DNA-Damaging Agents. Mol. Cell Biol. 1989, 9, 4196-4203.
17. Marx, J. New Link Found between P53 and DNA Repair. Science 1994, 266, 1321-1322.
18. Zhan, Q.; Chen, I. T.; Antinore, M. J.; Fornace, A. J., Jr. Tumor Suppressor P53 Can Participate in Transcriptional Induction of the Gadd45 Promoter in the Absence of Direct DNA Binding. Mol. Cell. Biol. 1998, 18, 2768-2778.
19. Jackson, J. G.; Pereira-Smith, O. M. P53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes P21 and Gadd45 During Replicative Senescence of Normal Human Fibroblasts. Cancer Res. 2006, 66, 8356-8360.
20. Kearsey, J. M.; Coates, P. J.; Prescott, A. R.; Warbrick, E.; Hall, P. A. Gadd45 Is a Nuclear Cell Cycle Regulated Protein Which Interacts with P21cip1. Oncogene 1995, 11, 1675-1683.
21. Marhin, W. W.; Chen, S.; Facchini, L. M.; Fornace, A. J., Jr.; Penn, L. Z. Myc Represses the Growth Arrest Gene Gadd45. Oncogene 1997, 14, 2825-2834.
22. Maeda, T.; Sim, A. B.; Leedel, D. A.; Chua, P. P.; Chomey, E. G.; Luong, L.; Tron, V. A. UV Induces Gadd45 in a P53-Dependent and -Independent Manner in Human Keratinocytes. J. Cutan. Med. Surg. 2003, 7, 119-123.
23. Papathanasiou, A.; Kerr, C.; Robbins, H.; McBride, W.; Alamo, I., Jr.; Barrett, F.; Hickson, D.; Fornace, A. J., Jr. Induction by Ionizing Radiation of the Gadd45 Gene in Cultured Human Cells: Lack of Mediation by Protein Kinase C. Mol. Cell. Biol. 1991, 11, 1009-1016.
24. Zhan, Q.; Carrier, F.; Fornace, A. J., Jr. Induction of Cellular P53 Activity by DNA-Damaging Agents and Growth Arrest. Mol. Cell. Biol. 1993, 13, 4242-4250.
25. Hirose, T.; Sowa, Y.; Takahashi, S.; Saito, S.; Yasuda, C.; Shindo, N.; Furuichi, K.; Sakai, T. P53-Independent Induction of Gadd45 by Histone Deacetylase Inhibitor: Coordinate Regulation by Transcription Factors Oct-1 and NF-Y. Oncogene 2003, 22, 7762-7773.
26. Yoshida, T.; Maeda, A.; Horinaka, M.; Shiraishi, T.; Nakata, S.; Wakada, M.; Yogosawa, S.; Sakai, T. Quercetin Induces Gadd45 Expression through a P53-Independent Pathway. Oncol. Rep. 2005, 14, 1299-1303.
27. Zhao, H.; Jin, S.; Antinore, M. J.; Lung, F. D.; Fan, F.; Blanck, P.; Roller, P.; Fornace, A. J., Jr.; Zhan, Q. The Central Region of Gadd45 Is Required for Its Interaction with P21/Waf1. Exp. Cell. Res. 2000, 258, 92-100.
28. Jin, S.; Antinore, M. J.; Lung, F. D.; Dong, X.; Zhao, H.; Fan, F.; Colchagie, A. B.; Blanck, P.; Roller, P. P.; Fornace, A. J., Jr.; Zhan, Q. The Gadd45 Inhibition of Cdc2 Kinase Correlates with Gadd45-Mediated Growth Suppression. J. Biol. Chem. 2000, 275, 16602-16608.
29. Mita, H.; Tsutsui, J.; Takekawa, M.; Witten, E.; Saito, H. Regulation of Mtk1/Mekk4 Kinase Activity by Its Nterminal Autoinhibitory Domain and Gadd45 Binding. Mol. Cell. Biol. 2002, 13, 4544-4555.
30. Paunesku, T.; Mittal, S.; Protić, M.; Oryhon, J.; Korolev, S. V.; Joachimiak, A.; Woloschak, G. E. Proliferating Cell Nuclear Antigen (Pcna): Ringmaster of the Genome. Int. J. Radiat. Biol. 2001, 77, 1007-1021.
31. Bulavin, D.; Kovalsky, O.; Hollander, M. C.; Fornace, A. Loss of Oncogenic H-Ras-Induced Cell Cycle Arrest and P38 Mitogen-Activated Protein Kinase Activation by Disruption of Gadd45β. Mol. Cell Biol. 2003, 23, 3859-3871.
32. Kovalsky, O.; Lung, F. D.; Roller, P. P.; Fornace, A. J., Jr. Oligomerization of Human Gadd45β Protein. J. Biol. Chem. 2001, 276, 39330-39339.
33. Wang, X. W.; Zhan, Q.; Coursen, J. D.; Khan, M. A.; Kontny, H. U.; Yu, L.; Hollander, M. C.; O'Connor, P. M.; Fornace, A. J., Jr.; Harris, C. C. Gadd45 Induction of a G2/M Cell Cycle Checkpoint. Proc. Natl. Acad. Sci. USA 1999, 96, 3706-3711.
34. Yoo, J.; Ghiassi, M.; Jirmanova, L.; Balliet, A. G.; Hoffman, B.; Fornace, A. J., Jr.; Liebermann, D. A.; Bottinger, E. P.; Roberts, A. B. Transforming Growth Factor-B-Induced Apoptosis Is Mediated by Smad-Dependent Expression of Gadd45γ through P38 Activation. J. Biol. Chem. 2003, 278, 43001-43007.
35. Papa, S.; Monti, S. M.; Vitale, R. M.; Bubici, C.; Jayawardena, S.; Alvarez, K.; De Smaele, E.; Dathan, N.; Pedone, C.; Ruvo, M.; Franzoso, G. Insights into the Structural Basis of the Gadd45beta-Mediated Inactivation of the Jnk Kinase, Mkk7/Jnkk2. J. Biol. Chem. 2007, 282, 19029-19041.
36. Lu, B.; Yu, H.; Chow, C.; Li, B.; Zheng, W.; Davis, R. J.; Flavell, R. A. Gadd45gamma Mediates the Activation of the P38 and Jnk Map Kinase Pathways and Cytokine Production in Effector T(H)1 Cells. Immunity 2001, 14, 583-590.
37. Hollander, M. C.; Kovalsky, O.; Salvador, J. M.; Kim, K. E.; Patterson, A. D.; Haines, D. C.; Fornace, A. J., Jr. Dimethylbenzanthracene Carcinogenesis in Gadd45a-Null Mice Is Associated with Decreased DNA Repair and Increased Mutation Frequency. Cancer Res. 2001, 61, 2487-2491.
38. Maeda, T.; Hanna, A. N.; Sim, A. B.; Chua, P. P.; Chong, M. T.; Tron, V. A. Gadd45 Regulates G2/M Arrest, DNA Repair, and Cell Death in Keratinocytes Following Ultraviolet Exposure. J. Invest. Dermatol. 2002, 119, 22-26.
39. Abdollahi, A.; Azam, N.; Balliet, A.; Hollander, C.; Hoffman, B.; Fornace, A. J., Jr; Liebermann, D. A. Cell Signalling: Cell Survival and a Gadd45-Factor Deficiency. Nature 2003, 424, 741.
40. Fornace, A. J.; Jackman, J.; Hollander, M. C.; Hoffman-Liebermann, B.; Liebermann, D. A. Genotoxic-Stress-Response Genes and Growtharrest Genes: Gadd, Myd, and Other Genes Induced by Treatments Eliciting Growth Arrest. Ann. N.Y. Acad. Sci. 1992, pp. 139-154.
41. Selvakumaran, M.; Lin, H. K.; Tjin Tham Sjin, R.; Reed, J.; Liebermann, D. A.; Hoffman, B. The Novel Primary Response Gene Myd118 and the Proto-Oncogenes Myb, Myc and Bcl-2 Modulate Transforming Growth Factor B1-Induced Apoptosis of Myeloid Leukemia Cells. Mol. Cell. Biol. 1994, 14, 2352-2360.
42. Takekawa, M.; Tatebayashi, K.; Itoh, F.; Adachi, M.; Imai, K.; Saito, H. Smad-Dependent Gadd45beta Expression Mediates Delayed Activation of P38 Map Kinase by Tgf-Beta. EMBO J. 2002, 21, 6473-6482.
43. De Smaele, E.; Zazzeroni, F.; Papa, S.; Nguyen, D. U.; Jin, R.; Jones, J.; Cong, R.; Franzoso, G. Induction of Gadd45beta by Nf-Kappab Downregulates Pro-Apoptotic Jnk Signalling. Nature 2001, 414, 308-313.
44. Larsen, C. M.; Døssing, M. G.; Papa, S.; Franzoso, G.; Billestrup, N.; Mandrup-Poulsen, T. Growth Arrest- and DNA-Damage-Inducible 45β Gene Inhibits C-Jun N-Terminal Kinase and Extracellular Signal-Regulated Kinase and Decreases Il-1B-Induced Apoptosis in Insulin-Producing Ins-1e Cells. Diabetologia 2006, 49, 980-989.
45. Gupta, M.; Gupta, S. K.; Balliet, A. G.; Hollander, M. C.; Fornace, A. J.. Jr.; Hoffman, B.; Liebermann, D. A. Hematopoietic Cells from Gadd45α- and Gadd45β-Deficient Mice Are Sensitized to Genotoxic-Stress-Induced Apoptosis. Oncogene 2005, 24, 7170-7179.
46. Engelmann, A.; Speidel, D.; Bornkamm, G. W.; Deppert, W.; Stocking, C. Gadd45B Is a Pro-Survival Factor Associated with Stress-Resistant Tumors. Oncogene 2007, 27, 1429-1438.
47. Chung, H. K.; Yi, Y. W.; Jung, N. C.; Kim, D.; Suh, J. M.; Kim, H.; Park, K. C.; Kim, D. W.; Hwang, E. S.; Song, J. H.; Ku, B. J.; Han, H. J.; Ro, H. K.; Kim, J. M.; Shong, M. Gadd45gamma Expression Is Reduced in Anaplastic Thyroid Cancer and Its Reexpression Results in Apoptosis. J. Clin. Endocrinol. Metab. 2003, 88, 3913-3920.
48. Zhang, X.; Sun, H.; Danila, D. C.; Johnson, S. R.; Zhou, Y.; Swearingen, B.; Zhuo, Y. Loss of Expression of Gadd45 Gamma, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for Tumorigenesis. J. Clin. Endocrinol. Metab. 2002, 87, 1262-1267.
49. Sun, L.; Gong, R.; Wan, B.; Huang, X.; Wu, C.; Zhang, X.; Zhao, X.; Yu, L. Gadd45gamma, Down-Regulated in 65% Hepatocellular Carcinoma (Hcc) from 23 Chinese Patients, Inhibits Cell Growth and Induces Cell Cycle G2/M Arrest for Hepatoma Hep-G2 Cell Lines. Mol. Biol. Rep. 2003, 30, 249-253.
50. Ying, J.; Srivastava, G.; Hsieh, W. S.; Gao, Z.; Murray, P.; Liao, S. K.; Ambinder, R.; Tao, Q. The Stress-Responsive Gene Gadd45g Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors. Clin. Cancer Res. 2005, 11, 6442-6449.
51. Jiang, F.; Wang, Z. Gadd45γ Is Androgen-Responsive and Growth-Inhibitory in Prostate Cancer Cells. Mol. Cell. Endocrinol. 2004, 213, 121-129.
52. Zhang, W.; Hoffman, B.; Liebermann, D. A. Ectopic Expression of Myd118/Gadd45/Cr6 (Gadd45beta/Alpha/Gamma) Sensitizes Neoplastic Cells to Genotoxic Stress-Induced Apoptosis. Int. J. Oncol. 2001, 18, 749-757.
53. Chen, I. T.; Smith, M. L.; O'Connor, P. M.; Fornace, A. J., Jr. Direct Interaction of Gadd45 with Pcna and Evidence for Competitive Interaction of Gadd45 and P21waf1/Cip1 with PCNA. Oncogene 1995, 11, 1931-1937.
54. Azam, N.; Vairapandi, M.; Zhang, W.; Hoffman, B.; Liebermann, D. A. Interaction of Cr6 (Gadd45gamma ) with Proliferating Cell Nuclear Antigen Impedes Negative Growth Control. J. Biol. Chem. 2001, 276, 2766-2774.
55. Fan, W.; Richter, G.; Cereseto, A. B.; Beadling, C.; Smith, K. A. Cytokine Response Gene 6 Induces P21 and Regulates Both Cell Growth and Arrest. Oncogene 1999, 18, 6573-6582.
56. Hoffman, B.; Liebermann, D. A. Role of Gadd45 in Myeloid Cells in Response to Hematopoietic Stress. Blood Cells Mol. Dis. 2007, 39, 344-347.
57. Carrier, F.; Smith, M. L.; Bae, I.; Kilpatrick, K. E.; Lansing, T. J.; Chen, C. Y.; Engelstein, M.; Friend, S. H.; Henner, W. D.; Gilmer, T. M.; Michael, B. K.; Albert, J. F., Jr. Characterization of human Gadd45, a p53-regulated protein. J. Biol. Chem. 1994, 269, 32672-32677.
58. Baeuerle, P. A.; Baltimore, D. κb: A Specific Inhibitor of the NF-KB Transcription Factor. Science 1988, 242, 540-546.
59. Ghosh, S.; Gifford, A. M.; Riviere, L. R.; Tempst, P.; Nolan, G. P.; Baltimore, D. Cloning of the P50 DNA Binding Subunit of NF-κB: Homology to Rel and Dorsal. Cell 1990, 62, 1019-1029.
60. Kieran, M.; Blank, V.; Logeat, F.; Vandekerckhove, J.; Lottspeich, F.; Le Bail, O.; Urban, M. B.; Kourilsky, P.; Baeuerle, P. A.; Israel, A. The DNA Binding Subunit of NF-κB Is Identical to Factor Kbf1 and Homologous to the Rel Oncogene Product. Cell 1990, 62, 1001-1018.
61. Bours, V.; Villalobos, J.; Burd, P. R.; Kelly, K.; Siebenlist, U. Cloning of a Mitogen-Inducible Gene Encoding a κB DNA-Binding Protein with Homology to the Rel Oncogene and to Cell-Cycle Motifs. Nature 1990, 348, 76-80.
62. Meyer, R.; Hatada, E. N.; Hohmann, H. P.; Haiker, M.; Bartsch, C.; Rothlisberger, U.; Lahm, H. W.; Schaleger, E. J.; van Loon, A. P.; Scheiderelt, C. Cloning of the DNA-Binding Subunit of Human Nuclear Factor Kb: The Level of Its Mrna Is Strongly Regulated by Phorbol Ester or Tumor Necrosis Factor A. Proc. Natl. Acad. Sci. USA 1991, 88, 966-970.
63. Gilmore, T. D. NF-κB, κBf1, Dorsal and Related Matters. Cell 1990, 62, 841-843.
64. Lewin, B. Oncogenic Conversion by Regulatory Changes in Transcription Factors. Cell 1991, 64, 303-312.
65. Phillips, R. J.; Ghosh, S. Regulation of IkappaB beta in WEHI 231 mature B cells. Mol. Cell Biol. 1997, 17, 4390-4396.
66. Wulczyn, F. G.; Naumann, M.; Scheidereit, C. Candidate protooncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature 1992, 358, 597-599.
67. Bours, V.; Franzoso, G.; Azarenko, V.; Park, S.; Kanno, T.; Brown, K.; Siebenlist, U. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 1993, 72, 729-739.
68. Bundy, D. L.; McKeithan, T. W. Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA. J. Biol. Chem. 1997, 272, 33132-33139.
69. Nolan, G. P.; Fujita, T.; Bhatia, K.; Huppi, C.; Liou, H. C.; Scott, M. L.; Baltimore, D. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol. Cell Biol. 1993, 13, 3557-3566.
70. Ghosh, S.; May, M. J.; Kopp, E. B. NF-κB and Rel Protein: Evolutionarily Conserved Mediators of Immune Responses. Ann. Rev. Immunol. 1998, 16, 225-260.
71. Silverman, N.; Maniatis, T. NF-κB Signaling Pathways in Mammalian and Insect Innate Immunity. Genes 2001, 15, 2321-2342.
72. Karin, M.; Cao, Y.; Greten, F. R.; Li, Z. W. NF-KappaB in Cancer: From Innocent Bystander to Major Culprit. Nat. Rev. Cancer 2002, 2, 301-310.
73. Siebenlist, U.; Franzoso, G.; Brown, K. Structure, Regulation and Function of NF-KappaB. Annu. Rev. Cell. Biol. 1994, 10, 405-455.
74. Grohmann, U.; Belladonna, M. L.; Bianchi, R.; Orabona, C.; Ayroldi, E.; Fioretti, M. C.; Puccetti, P. IL-12 Acts Directly on Dc to Promote Nuclear Localization of NF-KappaB and Primes Dc for IL-12 Production. Immunity 1998, 9, 315-323.
75. Maggirwar, S. B.; Sarmiere, P. D.; Dewhurst, S.; Freeman, R. S. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J. Neurosci. 1998, 18, 10356-10365.
76. Chaturvedi, M. M.; Higuchi, M.; Aggarwal, B. B. Effect of Tumor Necrosis Factors, Interferons, Interleukins, and Growth Factors on the Activation of NF-Kappa B: Evidence for Lack of Correlation with Cell Proliferation. Lymphokine Cytokine Res. 1994, 13, 309-313.
77. Wu, Z.; Miyamoto, S. Many Faces of NF-KappaB Signaling Induced by Genotoxic Stress. J. Mol. Med. 2007, 85, 1187-1202.
78. Cooper, S. J.; Bowden, G. T. Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-Kappa B (NFKappaB) and Activator Protein-1 (AP-1) in Uvb-Induced Skin Carcinogenesis. Curr. Cancer Drug Targets 2007, 7, 325-334.
79. Shumilla, J. A.; Wetterhahn, K. E.; Barchowsky, A. Inhibition of NF-Kappa B Binding to DNA by Chromium, Cadmium, Mercury, Zinc, and Arsenite in vitro: Evidence of a Thiol Mechanism. Arch. Biochem. Biophys. 1998, 349, 356-362.
80. Dieguez-Acuña, F. J.; Polk, W. W.; Ellis, M. E.; Simmonds, P. L.; Kushleika, J. V.; Woods, J. S. Nuclear Factor KappaB Activity Determines the Sensitivity of Kidney Epithelial Cells to Apoptosis: Implications for Mercury-Induced Renal Failure. Toxicol. Sci. 2004, 82, 114-123.
81. Pahl, H. L. Activators and Target Genes of Rel/NF-κB Transcription Factors. Oncogene 1999, 18, 6853-6866.
82. Mercurio, F.; Zhu, H.; Murray, B. W.; Shevchenko, A.; Bennett, B. L.; Li, J.; Young, D. B.; Barbosa, M.; Mann, M.; Manning, A.; Rao, A. Ikk-1 and Ikk-2: Cytokine-Activated Ikappab Kinases Essential for Nf-KappaB Activation. Science 1997, 278, 860-866.
83. DiDonato, J. A.; Hayakawa, M.; Rothwarf, D. M.; Zandi, E.; Karin, M. A. Cytokine-Responsive Iκb Kinase That Activates the Transcription Factor NF-κB. Nature 1997, 388, 548-554.
84. Régnier, C. H.; Song, H. Y.; Gao, X.; Goeddel, D. V.; Cao, Z.; Rothe, M. Identification and Characterization of an IkappaB Kinase. Cell 1997, 90, 373-383.
85. Papa, S.; Zazzeroni, F.; Pham, C. G.; Bubici, C.; Franzoso, G. Linking JNK Signaling to Nf-KappaB: A Key to Survival. J. Cell Sci. 2004, 117, 5197-5208.
86. Senftleben, U.; Cao, Y.; Xiao, G.; Greten, F. R.; Krähn, G.; Bonizzi, G.; Chen, Y.; Hu, Y.; Fong, A.; Sun, S. C.; Karin, M. Activation by IKKalpha of a Second, Evolutionary Conserved, NF-Kappa B Signaling Pathway. Science 2001, 293, 1495-1499.
87. Xiao, G.; Harhaj, E. W.; Sun, S. C. NF-KappaB-Inducing Kinase Regulates the Processing of NF-KappaB2 P100. Mol. Cell 2001, 7, 401-409.
88. Ware, C. F.; Ghosh, G.; Verma, I. M.; Hoffmann, A. A Fourth IkappaB Protein within the NF-KappaB Signaling Module. Cell 2007, 128, 369-381.
89. O'Dea, E. L.; Barken, D.; Peralta, R. Q.; Tran, K. T.; Werner, S. L.; Kearns, J. D.; Levchenko, A.; Hoffmann, A. A Homeostatic Model of IkappaB Metabolism to Control Constitutive NF-KappaB Activity. Mol. Syst. Biol. 2007, 3, 111-119.
90. Orlowski, R. Z.; Baldwin, A. S., Jr. NF-KappaB as a Therapeutic Target in Cancer. Trends Mol. Med. 2002, 8, 385-389.
91. Greten, F. R.; Eckmann, L.; Greten, T. F.; Park, J. M.; Li, Z. W.; Egan, L. J.; Kagnoff, M. F.; Karin, M. Ikkbeta Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer. Cell 2004, 118, 285-296.
92. Kucharczak, J.; Simmons, M. J.; Fan, Y. J.; Gélinas, C. To Be, or Not to Be: NF-κB Is the Answer - Role of Rel/NF-κB in the Regulation of Apoptosis. Oncogene 2003, 22, 8961-8982.
93. La Rosa, F. A.; Pierce, J. W.; Sonenshein, G. E. Differential Regulation of the C-Myc Oncogene Promoter by the NF-KappaB Rel Family of Transcription Factors. Mol. Cell. Biol. 1994, 14, 1039-1044.
94. Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. NF-KappaB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition. Mol. Cell. Biol. 1999, 19, 2690-2698.
95. Andela, V. B.; Schwarz, E. M.; Puzas, J. E.; O'Keefe, R. J.; Rosier, R. N. Tumor Metastasis and the Reciprocal Regulation of Prometastatic and Antimetastatic Factors by Nuclear Factor KappaB. Cancer Res. 2000, 60, 6557-6562.
96. Dikov, M. M.; Oyama, T.; Cheng, P.; Takahashi, T.; Takahashi, K.; Sepetavec, T.; Edwards, B.; Adachi, Y.; Nadaf, S.; Daniel, T.; Gabrilovich, D. I.; Carbone, D. P. Vascular Endothelial Growth Factor Effects on Nuclear Factor-Kappab Activation in Hematopoietic Progenitor Cells. Cancer Res. 2001, 61, 2015-2021.
97. Oyama, T.; Ran, S.; Ishida, T.; Nadaf, S.; Kerr, L.; Carbone, D. P.; Gabrilovich, D. I. Vascular Endothelial Growth Factor Affects Dendritic Cell Maturation through the Inhibition of Nuclear Factor-Kappa B Activation in Hemopoietic Progenitor Cells. J. Immunol. 1998, 160, 1224-1232.
98. Yin, L.; Hubbard, A. K.; Giardina, C. NF-Kappa B Regulates Transcription of the Mouse Telomerase Catalytic Subunit. J. Biol. Chem. 2000, 275, 36671-36675.
99. Hosoi, F.; Yasumoto, K.; Izumi, H.; Kohno, K.; Umezawa, K.; Iguchi, H.; Shirouzu, K.; Takamori, S.; Kuwano, M.; Ono, M. Inflammatory Stimuli from Macrophages and Cancer Cells Synergistically Promote Tumor Growth and Angiogenesis. Cancer Sci. 2007, 98, 2009-2018.
100. Prasad, S.; Ravindran, J.; Aggarwal, B. B. NF-kappaB and cancer: how intimate is this relationship. Mol. Cell Biochem. 2009, Online Epub version.
101. Davis, R. E.; Brown, K. D.; Siebenlist, U.; Staudt, L. M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 2001, 194, 1861-1874.
102. Bharti, A. C.; Donato, N.; Singh, S. Aggarwal, B. B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003, 101, 1053-1062.
103. Kordes, U.; Krappmann, D.; Heissmeyer, V.; Ludwig, W. D.; Scheidereit, C. Transcription factor NF-kappaB is constitutively ac tivated in acute lymphoblastic leukemia cells. Leukemia 2000, 14, 399-402.
104. Mann, A. P.; Verma, A.; Sethi, G.; Manavathi, B.; Wang, H.; Fok, J. Y.; Kunnumakkara, A. B.; Kumar, R.; Aggarwal, B. B.; Mehta, K. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res. 2006, 66, 8788-8795.
105. Shukla, S.; Maclennan, G. T.; Marengo, S. R.; Resnick, M. I.; Gupta, S. Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005, 64, 224-239.
106. Yang, J.; Richmond, A. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res. 2001, 61, 4901-4909.
107. Baby, J.; Pickering, B. F.; Vashisht Gopal, Y. N.; Van Dyke, M. W. Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. Cancer Lett. 2007, 255, 85-94.
108. Perkins, N. D. NF-κB: Tumor Promoter or Suppressor? Trends Cell. Biol. 2004, 14, 64-69.
109. Campbell, K. J.; Rocha, S.; Perkins, N. D. Active Repression of Antiapoptotic Gene Expression by Rela(P65) NF-Kappa B. Mol. Cell. Biol. 2004, 13, 853-865.
110. Li, N.; Karin, M. Ionizing Radiation and Short Wavelength UV Activate NF-KappaB through Two Distinct Mechanisms. Proc. Natl. Acad. Sci. USA 1998, 95, 13012-13017.
111. Ryan, K. M.; Ernst, M. K.; Rice, N. R.; Vousden, K. H. Role of NF-KappaB in P53-Mediated Programmed Cell Death. Nature 2000, 404, 892-897.
112. Stark, L. A.; Dunlop, M. G. Nucleolar Sequestration of Rela (P65) Regulates NF-κB-Driven Transcription and Apoptosis. Mol. Cell. Biol. 2005, 25, 5985-6004.
113. Wiener, Z.; Ontsouka, E. C.; Jakob, S.; Torgler, R.; Falus, A.; Mueller, C.; Brunner, T. Synergistic Induction of the Fas (Cd95) Ligand Promoter by Max and NF-kappaB in Human Non-Small Lung Cancer Cells. Exp. Cell Res. 2004, 299, 227-235.
114. Kimura, M.; Haisa, M.; Uetsuka, H.; Takaoka, M.; Ohkawa, T.; Kawashima, R.; Yamatsuji, T.; Gunduz, M.; Kaneda, Y.; Tanaka, N.; Naomoto, Y. TNF Combined with IFN-Alpha Accelerates NF-KappaB-Mediated Apoptosis through Enhancement of FAS Expression in Colon Cancer Cells. Cell Death Differ. 2003, 10, 718-728.
115. Ravi, R.; Bedi, G. C.; Engstrom, L. W.; Zeng, Q.; Mookerjee, B.; Gélinas, C.; Fuchs, E. J.; Bedi, A. Regulation of Death Receptor Expression and Trail/Apo2l-Induced Apoptosis by NF-KappaB. Nat. Cell Biol. 2001, 3, 409-416.
116. Gapuzan, M. E.; Yufit, P. V.; Gilmore, T. D. Immortalized Embryonic Mouse Fibroblasts Lacking the RelA Subunit of Transcription Factor NF-KappaB Have a Malignantly Transformed Phenotype. Oncogene 2002, 21, 2484-2492.
117. Ricca, A.; Biroccio, A.; Trisciuoglio, D.; Cippitelli, M.; Zupi, G.; Del Bufalo, D. Rela over-Expression Reduces Tumorigenicity and Activates Apoptosis in Human Cancer Cells. Br. J. Cancer 2001, 85, 1914-1921.
118. Maeda, S.; Kamata, H.; Luo, J. L.; Leffert, H.; Karin, M. IKKbeta couples hepatocyte death to cytokinedriven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121, 977-990.
119. Seitz, C. S.; Lin, Q.; Deng, H.; Khavari, P. A. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-nB. Proc. Natl. Acad. Sci. USA 1998, 95, 2307-2312.
120. Schumm, K.; Rocha, S.; Caamano, J.; Perkins, N. D. Regulation of p53 tumour suppressor target gene expression by the p52 NFkappaB subunit. EMBO J. 2006, 25, 4820-4832.
121. Amundson, S. A.; Zhan, Q.; Penn, L. Z.; Fornace, J. A. Myc Suppresses Induction of the Growth Arrest Genes Gadd34, Gadd45, and Gadd153 by DNA-Damaging Agents. Oncogene 1998, 17, 2149-2154.
122. Thyss, R.; Virolle, V.; Imbert, V.; Peyron, J. F.; Aberdam, D.; Virolle, T. NF-KappaB/Egr-1/Gadd45 Are Sequentially Activated Upon UVB Irradiation to Mediate Epidermal Cell Death. EMBO J. 2005, 24, 128-137.
123. Song, L.; Li, J.; Zhang, D.; Liu, Z. G.; Ye, J.; Zhan, Q.; Shen, H. M.; Whiteman, M.; Huang, C. IKKbeta Programs to Turn on the Gadd45alpha-MKK4-JNK Apoptotic Cascade Specifically Via P50 NF-KappaB in Arsenite Response J. Cell Biol. 2006, 175, 607-617.
124. Bower, J. J.; Leonard, S. S.; Chen, F.; Shi, X. As(Iii) Transcriptionally Activates the Gadd45β Gene Via the Formation of H2O2. Free Radic. Biol. Med. 2006, 41, 285-294.
125. Zhang, N.; Ahsan, M. H.; Zhu, L.; Sambucetti, L. C.; Purchio, A. F.; West, D. B. NF-KappaB and Not the MAPK Signaling Pathway Regulates Gadd45beta; Expression During Acute Inflammation. J. Biol. Chem. 2005, 280, 21400-21408.
126. Jin, R.; De Smaele, E.; Zazzeroni, F.; Nguyen, D. U.; Papa, S.; Jones, J.; Cox, C.; Gelinas, C.; Franzoso, G. Regulation of the Gadd45beta Promoter by NF-KappaB. DNA Cell Biol. 2002, 21, 491-503.
127. Van Antwerp, D. J.; Martin, S. J.; Kafri, T.; Green, D. R.; Verma, I. M. Suppression of TNF-Alpha-Induced Apoptosis by NF-KappaB. Science 1996, 274, 787-789.
128. Anto, R. J.; Maliekal, T. T.; Karunagaran, D. L-929 Cells Harboring Ectopically Expressed Rela Resist Curcumin-Induced Apoptosis. J. Biol. Chem. 2000, 275, 15601-15604.
129. Granville, D. J.; Carthy, C. M.; Jiang, H.; Levy, J. G.; McManus, B. M.; Matroule, J. Y.; Piette, J.; Hunt, D. W. Nuclear Factor-KappaB Activation by the Photochemotherapeutic Agent Verteporfin. Blood 2000, 95, 256-262.
130. Bush, A.; Mateyak, M.; Dugan, K.; Obaya, A.; Adachi, S.; Sedivy, J.; Cole, M. C-Myc Null Cells Misregulate CAD and Gadd45 but Not Other Proposed C-Myc Targets. Genes Dev. 1998, 12, 3797-3802.
131. Demicco, E. G.; Kavanagh, K. T.; Romieu-Mourez, R.; Wang, X.; Shin, S. R.; Landesman-Bollag, E.; Seldin, D. C.; Sonenshein, G. E. Relb/P52 NF-kappaB Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor IkappaB-Alpha Expression and Promote Carcinogenesis of the Mammary Gland. Mol. Cell. Biol. 2005, 25, 10136-10147.
132. Claassen, G.; Hann, S. Myc-Mediated Transformation: The Repression Connection. Oncogene 1999, 18, 2925-2933.
133. Chang, D. W.; Claassen, G. F.; Hann, S. R.; Cole, M. D. The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic Versus Proliferative Signals. Mol. Cell. Biol. 2000, 20, 4309-4319.
134. Tao, H.; Umek, R. M. Reciprocal Regulation of Gadd45 by C/EBPa and c-Myc. DNA and Cell Biol. 1999, 18, 75-84.
135. Jung, N.; Yi, Y. W.; Kim, D.; Shong, M.; Hong, S. S.; Lee, H. S.; Bae, I. Regulation of Gadd45gamma Expression by C/EBP. Eur. J. Biochem. 2000, 267, 6180-6187.
136. Balliet, A. G.; Hollander, M. C.; Fornace, A. J., Jr.; Hoffman, B.; Liebermann, D. A. Comparative Analysis of the Genetic Structure and Chromosomal Mapping of the Murine Gadd45β/CR6 Gene. DNA Cell. Biol. 2003, 22, 457-468.
137. Sakon, S.; Xue, X.; Takekawa, M.; Sasazuki, T.; Okazaki, T.; Kojima, Y.; Piao, J. H.; Yagita, H.; Okumura, K.; Doi, T.; Nakano, H. NF-kappaB Inhibits TNF-Induced Accumulation of ROS That Mediate Prolonged MAPK Activation and Necrotic Cell Death. EMBO J. 2003, 22, 3898-3909.
138. Kamata, H.; Honda, S.; Maeda, S.; Chang, L.; Hirata, H.; Karin, M. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases. Cell 2005, 120, 649-661.
139. Lluis, J. M.; Buricchi, F.; Chiarugi, P.; Morales, A.; Fernandez-Checa, J. C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor- kappaB via c-SRC and oxidant-dependent cell death. Cancer Res. 2007, 67, 7368-7377.
140. Schrader, M.; Fahimi, H. D. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell Biol. 2004, 122, 383-393.
141. Apel, K.; Hirt, H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 2004, 55, 373-399.
142. Shi, X.; Dong, Z.; Huang, C.; Ma, W.; Liu, K.; Ye, J.; Chen, F.; Leonard, S. S.; Ding, M.; Castranova, V.; Vallyathan, V. The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kB. Mol. Cell. Biochem.1999, 194, 63-70.
143. Schmidt, K. N.; Amstad, P.; Cerutti, P.; Baeuerle, P. A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF- kB. Chem. Biol. 1995, 2, 13-22.
144. Schreck, R.; Albermann, K.; Baeuerle, P. A. Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Res. Commun. 1992, 17, 221-237.
145. Zheng, X.; Zhang, Y.; Chen, Y. Q.; Castranova, V.; Shi, X.; Chen, F. Inhibition of NF-kappaB Stabilizes Gadd45alpha mRNA. Biochem. Biophys. Res. Commun. 2005, 329, 95-99.
146. Zhang, Y.; Lu, Y.; Ding, M.; Castranova, V.; Shi, X.; Chen, F. Deficiency in IKKbeta Gene Enhances Arsenic-Induced Gadd45alpha Expression. Mol. Cell Biochem. 2005, 279, 163-168.
147. Zhang, Y.; Bhatia, D.; Xia, H.; Castranova, V.; Shi, X.; Chen, F. Nucleolin Links to Arsenic-Induced Stabilization of Gadd45alpha mRNA. Nucleic Acids Res. 2006, 34, 485-495.
148. Mordret, G. Map Kinase Kinase: A Node Connecting Multiple Pathways. Biol. Cell. 1993, 79, 193-207.
149. Waskiewicz, A. J.; Cooper, J. A. Mitogen and Stress Response Pathways: Map Kinase Cascades and Phosphatase Regulation in Mammals and Yeast. Curr. Opin. Cell Biol. 1995, 7, 796-805.
150. Su, B.; Karin, M. Mitogen-Activated Protein Kinase Cascades and Regulation of Gene Expression. Curr. Opin. Immunol. 1996, 8, 402-411.
151. Miyake, Z.; Takekawa, M.; Ge, Q.; Saito, H. Activation of MTK1/MEKK4 by Gadd45 through Induced N-C Dissociation and Dimerization-Mediated Trans Autophosphorylation of the MTK1 Kinase Domain. Mol. Cell. Biol. 2007, 27, 2765-2776.
152. Schaeffer, H. J.; Weber, M. J. Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers. Mol. Cell. Biol. 1999, 19, 2435-2444.
153. Kuan, C. Y.; Yang, D. D.; Samanta, R. D. R.; Davis, R. J.; Rakic, P.; Flavell, R. A. The JNK1 and JNK2 Protein Kinases Are Required for Regional Specific Apoptosis During Early Brain Development. Neuron. 1999, 22, 667-676.
154. Adachi-Yamada, T.; Fujimura-Kamada, K.; Nishida, Y.; Matsumoto, K. Distortion of Proximodistal Information Causes JNKDependent Apoptosis in Drosophila Wing. Nature 1999, 400, 166-169.
155. Tournier, C.; Dong, C.; Turner, T. K.; Jones, S. N.; Flavell, R. A.; Davis, R. J. MKK7 Is an Essential Component of the JNK Signal Transduction Pathway Activated by Proinflammatory Cytokines. Genes Dev. 2001, 15, 1419-1426.
156. Craxton, A.; Shu, G.; Graves, J. D.; Saklatvala, J.; Krebs, E. G.; Clark, E. A. P38 MAPK Is Required for Cd40-Induced Gene Expression and Proliferation in B Lymphocytes. J. Immunol. 1998, 161, 3225-3236.
157. Hollenbach, E.; Neumann, M.; Vieth, M.; Roessner, A.; Malfertheiner, P.; Naumann, M. Inhibition of P38 Map Kinase- and Rick/NF-kappaB-Signaling Suppresses Inflammatory Bowel Disease. FASEB J. 2004, 18, 1550-1552.
158. Johnson, G. V.; Bailey, C. D. The P38 Map Kinase Signaling Pathway in Alzheimer's Disease. Exp. Neurol. 2003, 183, 263-269.
159. Nagata, Y.; Todokoro, K. Requirement of Activation of JNK and P38 for Environmental Stress-Induced Erythroid Differentiation and Apoptosis and of Inhibition of ERK for Apoptosis. Blood 1999, 94, 853-863.
160. Wang, Y.; Huang, S.; Sah, V. P.; Ross, J., Jr.; Brown, J. H.; Han, J.; Chien, K. R. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the P38 Mitogen-Activated Protein Kinase Family. J. Biol. Chem. 1998, 273, 2161-2168.
161. Chen, Z.; Gibson, T. B.; Robinson, F.; Silvestro, L.; Pearson, G.; Xu, B.; Wright, A.; Vanderbilt, C.; Cobb, M. H. Map Kinases. Chem. Rev. 2001, 101, 2449-2476.
162. Chang, L.; Karin, M. Mammalian Map Kinase Signalling Cascades. Nature 2001, 410, 37-40.
163. Saha, R. N.; Jana, M.; Pahan, K. MAPK P38 Regulates Transcriptional Activity of NF-kappaB in Primary Human Astrocytes Via Acetylation of P65. J. Immunol. 2007, 179, 7101-7109.
164. Tang, G.; Minemoto, Y.; Dibling, B.; Purcell, N. H.; Li, Z.; Karin, M.; Lin, A. Inhibition of JNK Activation through NF-kappaB Target Genes. Nature 2001, 414, 313-317.
165. Lewis, D.; Spandau, D. UVB-Induced Activation of NF-kappaB Is Regulated by the IGF-1R and Dependent on P38 MAPK. J. Invest. Dermatol. 2008, 128, 1022-1029.
166. Baeza-Raja, B.; Muñoz-Cánoves, P. P38 MAPK-Induced Nuclear Factor-kappaB Activity Is Required for Skeletal Muscle Differentiation: Role of Interleukin-6. Mol. Biol. Cell. 2004, 15, 2013-2026.
167. Takekawa, M.; Posas, F.; Saito, H. A Human Homolog of the Yeast Ssk2/Ssk22 Map Kinase Kinase Kinases, MTK1, Mediates Stress-Induced Activation of the P38 and JNK Pathways. EMBO J. 1997, 16, 4973-4982.
168. Gerwins, P.; Blank, J. L.; Johnson, G. L. Loning of a Novel Mitogen-Activated Protein Kinase Kinase Kinase, MEKK4, That Selectively Regulates the c-Jun Amino Terminal Kinase Pathway. J. Biol. Chem. 1997, 272, 8288-8295.
169. Wang, X.; Destrument, A.; Tournier, C. Physiological Roles of MKK4 and MKK7: Insights from Animal Models. Biochem. Biophys. Acta. 2006, 1773, 1349-1357.
170. Davis, R. J. Signal Transduction by the c-Jun N-Terminal Kinase. Biochem. Soc. Symp. 1999, 64, 1-12.
171. Nishina, H.; Wada, T.; Katada, T. Physiological Roles of SAPK/JNK Signaling Pathway. J. Biochem. (Tokyo) 2004, 136, 123-126.
172. Weston, C. R.; Davis, R. J. The JNK Signal Transduction Pathway. Curr. Opin. Genet. 2002, 12, 14-21.
173. Papa, S.; Zazzeroni, F.; Bubici, C.; Jayawardena, S.; Alvarez, K.; Matsuda, S.; Nguyen, D. U.; Pham, C. G.; Nelsbach, A. H.; Melis, T.; De Smaele, E.; Tang, W. J.; D'Adamio, L.; Franzoso, G. Gadd45β Mediates the NF-κB Suppression of JNK Signalling by Targeting MKK7/JNKK2. Nat. Cell Biol. 2004, 2, 146-153.
174. Tornatore, L.; Marasco, D.; Dathan, N.; Vitale, R. M.; Benedetti, E.; Papa, S.; Franzoso, G.; Ruvo, M.; Monti, S. M. Gadd45 Beta Forms a Homodimeric Complex That Binds Tightly to MKK7. J. Mol. Biol. 2008, 378, 97-111.
175. Moriguchi, T.; Toyoshima, F.; Masuyama, N.; Hanafusa, H.; Gotoh, Y.; Nishida, E. A Novel SAPK/JNK Kinase, MKK7, Stimulated by TNFalpha and Cellular Stresses. EMBO J. 1997, 16, 7045-7053.
176. Saitoh, M.; Nishitoh, H.; Fujii, M.; Takeda, K.; Tobiume, K.; Sawada, Y.; Kawabata, M.; Miyazono, K.; Ichijo, H. Mammalian Thioredoxin Is a Direct Inhibitor of Apoptosis Signal-Regulating Kinase (ASK) 1. EMBO J. 1998, 17, 2596-2606.
177. Kim, J. W.; Lee, J. E.; Kim, M. J.; Cho, E. G.; Cho, S. G.; Choi, E. J. Glycogen Synthase Kinase 3 Beta Is a Natural Activator of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 1 (MEKK1). J. Biol. Chem. 2003, 278, 13995-14001.
178. Lin, A.; Karin, M. NF-kappaB in Cancer: A Marked Target. Semin. Cancer Biol. 2003, 13, 107-114.
179. Lee, C. H.; Jeon, Y. T.; Kim, S. H.; Song, Y. S. NF-kappaB as a Potential Molecular Target for Cancer Therapy. Biofactors 2007, 29, 19-35.
180. Schultz, D. R.; Harrington, W. J., Jr. Apoptosis: Programmed Cell Death at a Molecular Level. Semin. Arthritis. Rheum. 2003, 32, 345-369.
181. Tak, P. P.; Firestein, G. S. NF-kappaB: A Key Role in Inflammatory Diseases. J. Clin. Invest. 2001, 107, 7-11.
182. Riedl, S. J.; Renatus, M.; Schwarzenbacher, R.; Zhou, Q.; Sun, C.; Fesik, S. W.; Liddington, R. C.; Salvesen, G. S. Structural Basis for the Inhibition of Caspase-3 by XIAP. Cell 2001, 104, 791-800.
183. Stennicke, H. R.; Ryan, C. A.; Salvesen, G. S. Reprieval from Execution: The Molecular Basis of Caspase Inhibition. Trends Biochem. Sci. 2002, 27, 94-101.
184. Huang, Y.; Park, Y. C.; Rich, R. L.; Segal, D.; Myszka, D. G.; Wu, H. Structural Basis of Caspase Inhibition by XIAP: Differential Roles of the Linker Versus the Bir Domain. Cell 2001, 104, 781-790.
185. Deveraux, Q. L.; Takahashi, R.; Salvesen, G. S.; Reed, J. C. XLinked Iap Is a Direct Inhibitor of Cell-Death Proteases. Nature 1997, 388, 300-304.
186. Conte, D.; Liston, P.; Wong, J. W.; Wright, K. E.; Korneluk, R. G. Thymocyte-Targeted Overexpression of XIAP Transgene Disrupts T Lymphoid Apoptosis and Maturation. Proc. Natl. Acad. Sci. USA 2001, 98, 5049-5054.
187. Harlin, H.; Reffey, S. B.; Duckett, C. S.; Lindsten, T.; Thompson, C. B. Characterization of XIAP-Deficient Mice. Mol. Cell. Biol. 2001, 21, 3604-3608.
188. Chen, F.; Castranova, V.; Li, Z.; Karin, M.; Shi, X. Inhibitor of Nuclear Factor Kappab Kinase Deficiency Enhances Oxidative Stress and Prolongs c-Jun NH2-Terminal Kinase Activation Induced by Arsenic. Cancer Res. 2003, 63, 7689-7693.
189. Maeda, S.; Chang, L.; Li, Z. W.; Luo, J. L.; Leffert, H.; Karin, M. IKKbeta Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating Tnfalpha. Immunity 2003, 19, 725-737.
190. Escárcega, R. O.; Fuentes-Alexandro, S.; García-Carrasco, M.; Gatica, A.; Zamora, A. The Transcription Factor Nuclear Factor-Kappa B and Cancer. Clin. Oncol. (R. Coll. Radiol.) 2007, 19, 154-161.
191. Karin, M. The Ikappab Kinase - a Bridge between Inflammation and Cancer. Cell Res. 2008, 18, 334-342.
192. Karin, M.; Greten, F. R. NF-kappaB: Linking Inflammation and Immunity to Cancer Development and Progression. Nat. Rev. Immunol. 2005, 5, 749-759.
193. Sarkar, F. H.; Li, Y. NF-kappaB: A Potential Target for Cancer Chemoprevention and Therapy. Front. Biosci. 2008, 13, 2950-2959.
194. Luo, J. L.; Kamata, H.; Karin, M. IKK/NF-kappaB Signaling: Balancing Life and Death--a New Approach to Cancer Therapy. J. Clin. Invest. 2005, 115, 2625-2632.
195. Greten, F. R.; Karin, M. The IKK/NF-κB Activation Pathway - a Target for Prevention and Treatment of Cancer. Cancer Lett. 2004, 206, 193-199.
196. Karin, M.; Yamamoto, Y.; Wang, Q. M. The IKK NF-kappaB System: A Treasure Trove for Drug Development. Nat. Rev. Drug Discov. 2004, 3, 17-26.
197. Ziegelbauer, K.; Gantner, F.; Lukacs, N. W.; Berlin, A.; Fuchikami, K.; Niki, T.; Sakai, K.; Inbe, H.; Takeshita, K.; Ishimori, M.; Komura, H.; Murata, T.; Lowinger, T.; Bacon, K. B. A Selective Novel Low-Molecular-Weight Inhibitor of IKappaB Kinase-Beta (IKK-Beta) Prevents Pulmonary Inflammation and Shows Broad Anti-Inflammatory Activity. Br. J. Pharmacol. 2005, 145, 178-192.
198. Frelin, C.; Imbert, V.; Griessinger, E.; Loubat, A.; Dreano, M.; Peyron, J. F. As602868, a Pharmacological Inhibitor of IKK2, Reveals the Apoptotic Potential of TNF-Alpha in Jurkat Leukemic Cells. Oncogene 2003, 22, 8187-8194.
199. Lagadec, P.; Griessinger, E.; Nawrot, M. P.; Fenouille, N.; Colosetti, P.; Imbert, V.; Mari, M.; Hofman, P.; Czerucka, D.; Rousseau, D.; Berad, E.; Dreano, M.; Peyron, J. F. Pharmacological Targeting of NF-kappaB Potentiates the Effect of the Topoisomerase Inhibitor CPT-11 on Colon Cancer Cells. Br. J. Cancer 2008, 98, 335-344.
200. Sowa, Y.; Sakai, T. Butyrate as a Model For "Gene-Regulating Chemoprevention and Chemotherapy." Biofactors 2000, 12, 283-287.
201. Zerbini, L. F.; Wang, Y.; Czibere, A.; Correa, R. G.; Cho, J. Y.; Ijiri, K.; Wei, W.; Joseph, M.; Gu, X.; Grall, F.; Goldring, M. B.; Zhou, J. R.; Libermann, T. A. NF-kappa B-Mediated Repression of Growth Arrest- and DNA-Damage-Inducible Proteins 45alpha and Gamma Is Essential for Cancer Cell Survival. Proc. Natl. Acad. Sci. USA 2004, 101, 13618-13623.
202. Qiu, W.; Zhou, B.; Zou, H.; Liu, X.; Chu, P. G.; Lopez, R.; Shih, J.; Chung, C.; Yen, Y. Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 Beta Promoter in Human Hepatocellular Carcinoma. Am. J. Pathol. 2004, 165, 1689-1699.
203. Qiu, W.; David, D.; Zhou, B.; Chu, P. G.; Zhang, B.; Wu, M.; Xiao, J.; Han, T.; Zhu, Z.; Wang, T.; Liu, X.; Lopez. R.; Frankel, P.; Jong, A.; Yen, Y. Down-Regulation of Growth Arrest DNA Damage-Inducible Gene 45beta Expression Is Associated with Human Hepatocellular Carcinoma. Am. J. Pathol. 2003, 162, 1961-1974.
204. Goffin, J.; Eisenhauer, E. DNA Methyltransferase Inhibitors-State of the Art. Ann. Oncol. 2002, 13, 1699-1716.
205. Davis, A. J.; Gelmon, K. A.; Siu, L. L.; Moore, M. J.; Britten, C. D.; Mistry, N.; Klamut, H.; D'Aloiso, S.; MacLean, M.; Wainman, N.; Ayers, D.; Firby, P.; Besterman, J. M.; Reid, G. K.; Eisenhauer, E. A. Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide Mg98 Given as a 21-Day Continuous Infusion Every 4 Weeks. Invest. New Drugs 2003, 21, 85-97.
206. Plimack, E. R.; Kantarjian, H. M.; Issa, J. P. Decitabine and Its Role in the Treatment of Hematopoietic Malignancies. Leuk. Lymphoma 2007, 48, 1472-1481.
207. Chen, Z.; Clark, S.; Birkeland, M.; Sung, C. M.; Lago, A.; Liu, R.; Kirkpatrick, R.; Johanson, K.; Winkler, J. D.; Hu, E. Induction and Superinduction of Growth Arrest and DNA Damage Gene 45 (Gadd45) Alpha and Beta Messenger Rnas by Histone Deacetylase Inhibitors Trichostatin a (Tsa) and Butyrate in Sw620 Human Colon Carcinoma Cells. Cancer Lett. 2002, 188, 127-140.
208. Kaminskas, E.; Farrell, A.; Abraham, S.; Baird, A.; Hsieh, L. S.; Lee, S. L.; Leighton, J. K.; Patel, H.; Rahman, A.; Sridhara, R.; Wang, Y. C.; Pazdur, R. Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes. Clin. Cancer Res. 2005, 11, 3604-3608.
209. Vigushin, D. M.; Ali, S.; Pace, P. E.; Mirsaidi, N.; Ito, K.; Adcock, I.; Coombes, R. C. Trichostatin a Is a Histone Deacetylase Inhibitor with Potent Antitumor Activity against Breast Cancer in vivo. Clin. Cancer Res. 2001, 7, 971-976.
210. Griffiths, E. A.; Gore, S. D. DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes. Semin. Hematol. 2008, 45, 23-30.
211. Chen, F.; Zhang, Z.; Leonard, S. S.; Shi, X. Contrasting Roles of NF-kappaB and JNK in Arsenite-Induced P53-Independent Expression of Gadd45β. Oncogene 2001, 20, 3585-3589.
212. Bode, A. M.; Dong, Z. The Paradox of Arsenic: Molecular Mechanisms of Cell Transformation and Chemotherapeutic Effects. Crit. Rev. Oncol. Hematol. 2002, 42, 5-24.
213. Dong, Z. The Molecular Mechanisms of Arsenic-Induced Cell Transformation and Apoptosis. Environ. Health Perspect. 2002, 110, 757-759.
214. Cohen, S. M.; Ohnishi, T.; Arnold, L. L.; Le, X. C. Arsenic-Induced Bladder Cancer in an Animal Model. Toxicol. Appl. Pharmacol. 2007, 222, 258-263.
215. Haque, R.; Mazumder, D. N.; Samanta, S.; Ghosh, N.; Kalman, D.; Smith, M. M.; Mitra, S.; Santra, A.; Lahiri, S.; Das, S.; De, B. K.; Smith, A. H. Arsenic in Drinking Water and Skin Lesions: Dose-Response Data from West Bengal, India. Epidemiology 2003, 14, 174-182.
216. Stephanopoulos, D. E.; Willman, D. A.; Shevlin, D.; Pinter, L.; Gummin, D. D. Treatment and Toxicokinetics of Acute Pediatric Arsenic Ingestion: Danger of Arsenic Insecticides in Children. Pediatr. Crit. Care Med. 2002, 3, 74-80.
217. Li, X.; Ding, X.; Adrian, T. E. Arsenic Trioxide Induces Apoptosis in Pancreatic Cancer Cells Via Changes in Cell Cycle, Caspase Activation, and Gadd Expression. Pancreas 2003, 27, 174-179.
218. Kwong, Y. L. Arsenic Trioxide in the Treatment of Haematological Malignancies. Expert. Opin. Drug Saf. 2004, 3, 589-597.
219. Bonati, A.; Rizzoli, V.; Lunghi, P. Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug. Curr. Pharm. Biotechnol. 2006, 7, 397-405.
220. Ouyang, W.; Ma, Q.; Li, J.; Zhang, D.; Liu, Z. G.; Rustgi, A. K.; Huang, C. Cyclin D1 Induction through Ikappab Kinase Beta/Nuclear Factor-Kappab Pathway Is Responsible for Arsenite-Induced Increased Cell Cycle G1-S Phase Transition in Human Keratinocytes. Cancer Res. 2005, 65, 9287-9293.
221. Wang, T.; Hu, Y. C.; Dong, S.; Fan, M.; Tamae, D.; Ozeki, M.; Gao, Q.; Gius, D.; Li, J. J. Co-Activation of ERK, NF-kappaB, and Gadd45beta in Response to Ionizing Radiation. J. Biol. Chem. 2005, 280, 12593-12601.
222. Zhan, Q.; Bae, I.; Kastan, M. B.; Fornace, A. J., Jr. The P53-Dependent Gamma-Ray Response of Gadd45. Cancer Res. 1994, 54, 2755-2760.
223. Koong, A. C.; Denko, N. C.; Hudson, K. M.; Schindler, C.; Swiersz, L.; Koch, C.; Evans, S.; lbrahim, H.; Le, D. T.; Terris, D. J.; Giaccia, A. J. Candidate Genes for the Hypoxic Tumor Phenotype. Cancer Res. 2000, 60, 883-887.
224. Miller, A. C.; Brooks, K.; Smith, J.; Page, N. Effect of the Militarily-Relevant Heavy Metals, Depleted Uranium and Heavy Metal Tungsten-Alloy on Gene Expression in Human Liver Carcinoma Cells (Hepg2). Mol. Cell. Biochem. 2004, 255, 247-256.
225. Liu, J.; Kadiiska, M. B.; Liu, Y.; Lu, T.; Qu, W.; Waalkes, M. P. Stress-Related Gene Expression in Mice Treated with Inorganic Arsenicals. Toxicol. Sci. 2001, 61, 314-320.
226. Zhan, Q.; Lord, K. A.; Alamo, I., Jr ; Hollander, M. C.; Carrier, F.; Ron, D.; Kohn, K. W.; Hoffman, B.; Liebermann, D. A.; Fornace, A. J., Jr. The Gadd and Myd Genes Define a Novel Set of Mammalian Genes Encoding Acidic Proteins That Synergistically Suppress Cell Growth. Mol. Cell. Biol. 1994, 14, 2361-2371.
227. Nakayama, K.; Hara, T.; Hibi, M.; Hirano, T.; Miyajima, A. A Novel Oncostatin M-Inducible Gene Oig37 Forms a Gene Family with Myd118 and Gadd45 and Negatively Regulates Cell Growth. J. Biol. Chem. 1999, 274, 24766-24772.
228. Fabbro, M.; Henderson, B. R. BARD1 Regulates BRCA1-Mediated Transactivation of the P21waf1/Cip1 and Gadd45 Promoters. Cancer Lett. 2008, 263, 189-196.
229. Somasundaram, K. Breast Cancer Gene 1 (BRCA1): Role in Cell Cycle Regulation and DNA Repair - Perhaps through Transcription. Cell Biochem. 2003, 88, 1084-1091.
230. Kastan, M. B.; Zhan, Q.; El-Deiry, W. S.; Carrier, F.; Jacks, T.; Walsh, W. V.; Plunkett, B. S.; Vogelstein, B.; Fornace, A. J., Jr. A Mammalian Cell Cycle Checkpoint Pathway Utilizing P53 and Gadd45 Is Defective in Ataxia-Telangiectasia. Cell 1992, 71, 587-597.
231. th; Umek, R. M. C/EBPalpha Regulation of the Growth-Arrest-Associated Gene Gadd45. Mol. Cell Biol. 1996, 16, 3878-3883.